JPMorgan Steps Aside From China Deal, Fearing Regulatory ScrutinyMani
JPMorgan Chase & Co. (NYSE:JPM) has stepped aside on a Chinese firm’s initial public offering amid investigations by U.S. regulators into its hiring practices in China.
The bank’s latest move to pull out from Tianhe Chemicals’ IPO follows its decision to exit from two more deals earlier.
Probe into JPMorgan’s hiring practice in China
As reported earlier,
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email email@example.com or click Chat.